|
Algesal® - 7 June 2005 |
 |
 |
 |
 |
 Zeroderma Ltd has today announced
the sale of its topical rubefacient product, ALGESAL®,
to Thornton & Ross
Ltd. The sale includes all intellectual property, trade marks
and stock holding relating to ALGESAL®.
Thornton & Ross Ltd will retain the product name and will continue to market the product using the current packaging style with only minor changes to comply with the United Kingdom’s regulatory requirements. ALGESAL® will continue to be available through the usual wholesalers. Paul Gibbons, Zeroderma’s General Manager, expressed his thanks to the retail and wholesale trade for their support of this product over the past year or so. Commenting on the sale, he expressed his delight that the product now had a long-term future under the new ownership of Thornton & Ross Ltd. Thornton & Ross Ltd is a leading manufacturer of medicines and personal care products based in Huddersfield, West Yorkshire. Dieno George, Thornton & Ross Chief Executive said, “Algesal fits well with T&R’s growing portfolio of market leading branded medicines and represents an important step toward strengthening its prescription and OTC medicines business”. |
 |
 |